Adverse effect of beta-adrenoreceptor antagonists, subs

This code signifies a harmful or undesirable reaction experienced by a patient due to the therapeutic use of a beta-blocker medication, occurring during a follow-up visit for the adverse effect. It indicates that the patient is receiving ongoing care for the consequences of the drug's side effects, rather than the initial presentation.

Use this code when a patient presents for continued management or monitoring of an adverse effect caused by a beta-adrenoreceptor antagonist. This includes scenarios such as follow-up appointments for bradycardia, hypotension, bronchospasm, or fatigue directly attributable to beta-blocker therapy. The "subsequent encounter" designation is crucial, indicating that the initial adverse event has already been addressed.

• Always sequence the code for the specific adverse effect (e.g., bradycardia, hypotension) first, followed by this adverse effect code.
• Ensure documentation clearly states the adverse effect is due to a beta-blocker and that this is a follow-up visit.
• Distinguish from initial encounters (A) or sequela (S) encounters; "D" is specifically for subsequent care.